Embolic Protection Devices Market

Market Overview:

The global embolic protection devices market size reached US$ 1,069 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,706 Million by 2028, exhibiting a growth rate (CAGR) of 8.3% during 2023-2028.

Embolic protection devices (EPD) trap blood and luminal debris within the saphenous vein graft (SVG) during stenting to prevent distal embolization. There are three classes of these devices, including distal occlusion devices, distal filters and proximal occlusion devices. These devices provide the most verified strategy to reduce periprocedural myocardial infarction (MI) and major adverse cardiovascular events by capturing and removing debris that may get dislodged during surgical procedures such as SVG interventions, percutaneous coronary intervention, aortic valve stenosis, etc.

The increasing prevalence of cardiovascular diseases (CVDs) represent one of the key factors driving the market growth. EPDs are crucial in reducing complications arising due to blockages in small blood vessels caused by the debris that is released into the bloodstream. They form a part of the most reliable, evidence-based procedure for reducing periprocedural MI and other major cardiovascular events. This, coupled with increasing instances of cardiac arrests and other heart-related issues, is providing a significant boost to the market for EPDs. Furthermore, governments of several nations across the globe are investing in increasing their research and development (R&D) capabilities, which is acting as another major growth-inducing factor. Steadily increasing geriatric population across the world, which is more susceptible to chronic medical illnesses, is also contributing to the market growth. The rising demand for minimally invasive products and several technological advancements, along with the significant growth in the healthcare sector, are some of the other factors that are expected to further create a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global embolic protection devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application, procedure, material, usage and end-user.

Breakup by Product:

• Distal Filter Devices
• Distal Occlusion Devices
• Proximal Occlusion Devices
   

Breakup by Application:

• Coronary Artery Treatment
• Carotid Artery Treatment
• Others
   

Breakup by Procedure:

• Percutaneous Coronary Intervention
• Carotid Artery Stenosis
• Saphenous Vein Graft Intervention
• Aortic Valve Stenosis (Transcatheter Aortic Valve Replacement)
• Others
   

Breakup by Material:

•  Nitinol
•  Polyurethane
   

Breakup by Usage:

• Disposable Devices
• Re-Usable Devices
   

Breakup by End-User:

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Allium Medical Solutions Ltd., Boston Scientific Corporation, Cardinal Health Inc., Contego Medical LLC, Innovative Cardiovascular Solutions LLC, Edwards Lifesciences Corporation, Medtronic Inc., Silk Road Medical Inc., etc.

Report Coverage: